ID: ALA4277989

Max Phase: Preclinical

Molecular Formula: C28H26N4O3

Molecular Weight: 466.54

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C(N1C[C@@H](O)C=C[C@@H]1COCc1ccccc1)n1cc(-c2ccc(-c3ccccc3)cc2)nn1

Standard InChI:  InChI=1S/C28H26N4O3/c33-26-16-15-25(20-35-19-21-7-3-1-4-8-21)31(17-26)28(34)32-18-27(29-30-32)24-13-11-23(12-14-24)22-9-5-2-6-10-22/h1-16,18,25-26,33H,17,19-20H2/t25-,26+/m1/s1

Standard InChI Key:  XIJZONOVYVLTTL-FTJBHMTQSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 466.54

Molecular Weight (Monoisotopic): 466.2005

AlogP: 4.40

#Rotatable Bonds: 6

Polar Surface Area: 80.48

Molecular Species: NEUTRAL

HBA: 6

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa:

CX LogP: 4.47

CX LogD: 4.47

Aromatic Rings: 4

Heavy Atoms: 35

QED Weighted: 0.43

Np Likeness Score: -0.34

References

1. Deng H, van der Wel T, van den Berg RJBHN, van den Nieuwendijk AMCH, Janssen FJ, Baggelaar MP, Overkleeft HS, van der Stelt M..  (2017)  Chiral disubstituted piperidinyl ureas: a class of dual diacylglycerol lipase-α and ABHD6 inhibitors.,  8  (5): [PMID:30108813] [10.1039/C7MD00029D]

Source

Source(1):

• Scientific Literature